AzTrials
AzTrials

Irreversible PulpitisNCT05568563

Comparison of Effectiveness of Pre-cooling With Ethyl Chloride Versus Honey

A study testing Ethyl chloride and Honey in people with Irreversible Pulpitis, run by Altamash Institute of Dental Medicine at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Comparing Pre-cooling with Ethyl Chloride versus Honey in Alleviating Intra-oral injection pain in Adult patients Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Irreversible Pulpitis
What is being tested?
Ethyl chloride and Honey
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 sitePakistan
Study dates
1 Aug 2022to 30 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • No medical history
  • Patients suffering from Symptomatic Irreversible Pulpitis requiring buccal infiltration

Who cannot join

  • Patients having any medical conditions considered to affect patient safety or the quality of the study
  • if they had any known hypersensitivity to local anaesthetics of amide type or any of the other contents in the substance used

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Hira Danish

    Karachi, Sindh, 75500

Other trials in Pakistan

About this study

Official title: Comparison of Effectiveness of Pre-cooling With Ethyl Chloride Versus Honey in Alleviating Intra-oral Injection Pain in Adult Patients

Comparing Pre-cooling with Ethyl Chloride versus Honey in Alleviating Intra-oral injection pain in Adult patients

Being tested
Ethyl chloride, Honey

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ethyl chlorideDrug

    Ethyl chloride is an agent that is widely used in dental practice as the standard modality for pulp vitality tests .

  • HoneyOther

    Honey is a natural dietary product

Study groups in NCT05568563
Study groupRoleWhat they receive
Ethyl chlorideExperimentalNot described
Receives: Drug: Ethyl chloride
HoneyExperimentalNot described
Receives: Other: Honey
ControlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To alleviate dental injection pain

    Post administration of oral local anesthetic infiltration pain will be measured by using Visual Analogue Scale(VAS) which is an 10-point scale from 0-10 where 0 represents no pain and 10 represents the worst pain measured

    Measured: immediately after completion of administration of oral local anesthetic infiltration within 60 seconds

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Oct 2022
  2. Study start1 Aug 2022
  3. Primary completion30 Sep 2022
  4. Study completion30 Sep 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05568563
Sponsor's protocol ID
Ethyl Chloride versus Honey
Status last verified
Oct 2022
First submitted
2 Oct 2022
Last updated
3 Nov 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Ethyl chloride and Honey in people with Irreversible Pulpitis, run by Altamash Institute of Dental Medicine at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To alleviate dental injection pain (time frame: immediately after completion of administration of oral local anesthetic infiltration within 60 seconds). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in